Staphylococcus aureus Capsular Polysaccharides

K O'Riordan, JC Lee - Clinical microbiology reviews, 2004 - Am Soc Microbiol
Serotype 5 and 8 capsular polysaccharides predominate among clinical isolates of
Staphylococcus aureus. The results of experiments in animal models of infection have …

Bacterial chondronecrosis with osteomyelitis ('femoral head necrosis') of broiler chickens: a review

PT McNamee, JA Smyth - Avian Pathology, 2000 - Taylor & Francis
Bacterial chondronecrosis with osteomyelitis (BCO) in chickens was first reported in 1972
and is now recognized as an important cause of lameness in broiler chickens. Recent …

A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge

AI Fattom, J Sarwar, A Ortiz, R Naso - Infection and immunity, 1996 - Am Soc Microbiol
The efficacy of capsular polysaccharide (CP)-specific antibodies elicited by active
immunization with vaccines composed of Staphylococcus aureus types 5 and 8 CP linked to …

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death.

IM Nilsson, JM Patti, T Bremell, M Höök… - The Journal of …, 1998 - Am Soc Clin Investig
Staphylococcus aureus is a major cause of nosocomial and community-acquired infections.
Morbidity and mortality due to infections such as sepsis, osteomyelitis, septic arthritis, and …

Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections

JI Flock - Molecular medicine today, 1999 - cell.com
Staphylococcal infections cause a number of serious diseases, ranging from acute
septicaemia to chronic problems such as osteomyelitis and septic arthritis. Resistance to …

c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection

DL Hu, K Narita, M Hyodo, Y Hayakawa, A Nakane… - Vaccine, 2009 - Elsevier
Cyclic diguanylate (c-di-GMP) is a novel immunomodulator and immune enhancer that
triggers a protective host innate immune response. The protective effect of c-di-GMP as a …

The prospects for developing a vaccine against Stapphylococcus aureus

JC Lee - Trends in microbiology, 1996 - Elsevier
Staphyloccus aureus is an important bacterial pathogen with multiple virulence factors. The
prevalence of antibiotic resistance among clinical isolates means that new vaccine …

Vaccination with Nontoxic Mutant Toxic Shock Syndrome Toxin 1 Protects against Staphylococcus aureus Infection

DL Hu, K Omoe, S Sasaki, H Sashinami… - The Journal of …, 2003 - academic.oup.com
To investigate whether vaccination with nontoxic mutant toxic shock syndrome toxin 1
(mTSST-1) can protect against Staphylococcus aureus infection, mice were vaccinated with …

Immunization with FimA protects against Streptococcus parasanguis endocarditis in rats

HB Viscount, CL Munro, D Burnette-Curley… - Infection and …, 1997 - Am Soc Microbiol
FimA, a surface-associated protein of Streptococcus parasanguis, is associated with initial
colonization of damaged heart tissue in an endocarditis model (D. Burnette-Curley, V. Wells …

Collagen binding protein compositions and methods of use

M Höök, JM Patti, K House-Pompeo… - US Patent …, 2001 - Google Patents
Disclosed are the cna gene and cna-derived nucleic acid segments from Staphylococcus
aureus, and DNA segments encoding cna from related bacteria. Also disclosed are Col …